The GCKR-P446L gene variant predisposes to raised blood cholesterol and lower blood glucose in the P446L mouse-a model for GCKR rs1260326-Reference-Cited by-同舟云学术

The GCKR-P446L gene variant predisposes to raised blood cholesterol and lower blood glucose in the P446L mouse-a model for GCKR rs1260326

Published:2023-06 Issue: Volume:72 Page:101722
ISSN:2212-8778
Container-title:Molecular Metabolism
language:en
Short-container-title:Molecular Metabolism

Author:

Ford Brian E.,Chachra Shruti S.,Rodgers Katrina,Moonira Tabassum,Al-Oanzi Ziad H.,Anstee Quentin M.,Reeves Helen L.,Schattenberg Jörn M.,Fairclough Rebecca J.,Smith David M.,Tiniakos Dina,Agius Loranne^ORCID

Funder

European Commission

Horizon 2020

European Paediatric Orthopaedic Society

NIHR Newcastle Biomedical Research Centre

Medical Research Council

Newcastle University

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference80 articles.

1. The trans-ancestral genomic architecture of glycemic traits;Chen;Nat Genet,2021

2. Genetics of hypertriglyceridemia;Dron;Front Endocrinol,2020

3. The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes;Sparsø;Diabetologia,2008

4. The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population;Vaxillaire;Diabetes,2008

5. Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations;Orho-Melander;Diabetes,2008

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Compromised chronic efficacy of a glucokinase activator AZD1656 in mouse models for common human GCKR variants;Biochemical Pharmacology;2024-11

2. Compromised chronic efficacy of a Glucokinase Activator AZD1656 in mouse models for common humanGCKRvariants;2024-07-24

3. Interplay of Mediterranean-diet adherence, genetic factors, and metabolic dysfunction-associated steatotic liver disease risk in Korea;Journal of Translational Medicine;2024-06-25

4. Genetic predisposition to metabolic dysfunction-associated fatty liver disease;CHILD`S HEALTH;2024-05-26

5. Observational and genetic analyses clarify the relationship between type 2 diabetes mellitus and gallstone disease;Frontiers in Endocrinology;2024-01-31